首页> 外文期刊>Clinical rheumatology >Glucocorticoid receptor genetic polymorphisms is associated with improvement of health-related quality of life in Chinese population with systemic lupus erythematosus
【24h】

Glucocorticoid receptor genetic polymorphisms is associated with improvement of health-related quality of life in Chinese population with systemic lupus erythematosus

机译:糖皮质激素受体基因多态性与系统性红斑狼疮患者健康相关的生活质量改善相关

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In our previous study, we found that glucocorticoid receptor (GR) gene genetic polymorphisms may play a major role in the efficacy of glucocorticoids (GCs) in Chinese systemic lupus erythematosus (SLE) patients. The aim of this study is to explore the association of GR gene genetic polymorphisms and improvement of health-related quality of life (HRQOL) in Chinese SLE patients treated with GCs. A total of 195 Chinese SLE patients were treated with GCs for 12 weeks. The HRQOL of patients was measured with the Medical Outcomes Study Short Form-36 (SF-36) at baseline and 12 weeks. Polymorphisms of GR gene were genotyped by using multiplex SNaPshot method. One hundred eighty-four patients (94.36 %) completed the 12-week follow-up. Twenty-three single-nucleotide polymorphisms of GR gene were genotyped. There was a significant association between rs10482672 polymorphism and improvement in physical function (P = 0.043), general health (P = 0.024), and social function (P = 0.013). The rs12656106 polymorphism was associated with improvement in the total score of SF-36 (P = 0.014), physical function (P = 0.013), general health (P = 0.010), vitality (P = 0.015), social function (P = 0.004), physical component summary (P = 0.016), and mental component summary (P = 0.014). The rs4912905 polymorphism was associated with improvement in bodily pain (P = 0.040) and general health (P = 0.038). The rs4912911 polymorphism was associated with improvement in general health (P = 0.026) and vitality (P = 0.027). The rs4986593 polymorphism was associated with improvement in bodily pain (P = 0.034). The rs7719514 polymorphism was associated with improvement in vitality (P = 0.002) and mental component summary (P = 0.041). We also found a significant association between rs9324924 polymorphism and improvement in physical function (P = 0.040), bodily pain (P = 0.007), and general health (P = 0.019). These results indicate that there may be an association of GR gene rs10482672, rs12656106, rs4912905, rs4912911, rs4986593, rs7719514, and rs9324924 polymorphisms with improvement of HRQOL in Chinese SLE patients treated with GCs.
机译:在我们以前的研究中,我们发现糖皮质激素受体(GR)基因多态性可能在中国系统性红斑狼疮(SLE)患者的糖皮质激素(GCs)疗效中起主要作用。这项研究的目的是探讨GR基因遗传多态性与GC治疗的中国SLE患者健康相关生活质量(HRQOL)的改善之间的关系。总共195名中国SLE患者接受了GC治疗12周。患者的HRQOL在基线和第12周用医学成果研究简表36(SF-36)进行测量。利用多重SNaPshot方法对GR基因的多态性进行基因分型。 184位患者(94.36%)完成了12周的随访。对GR基因的二十三个单核苷酸多态性进行了基因分型。 rs10482672多态性与身体功能(P = 0.043),总体健康(P = 0.024)和社交功能(P = 0.013)的改善之间存在显着关联。 rs12656106多态性与SF-36的总评分(P = 0.014),身体功能(P = 0.013),总体健康(P = 0.010),活力(P = 0.015),社会功能(P = 0.004)的改善有关),身体成分摘要(P = 0.016)和精神成分摘要(P = 0.014)。 rs4912905多态性与身体疼痛(P = 0.040)和总体健康状况(P = 0.038)改善相关。 rs4912911多态性与整体健康状况(P = 0.026)和活力(P = 0.027)改善有关。 rs4986593多态性与身体疼痛的改善相关(P = 0.034)。 rs7719514基因多态性与活力改善(P = 0.002)和精神成分汇总(P = 0.041)相关。我们还发现rs9324924多态性与身体功能的改善(P = 0.040),身体疼痛(P = 0.007)和一般健康状况(P = 0.019)之间存在显着关联。这些结果表明,在用GCs治疗的中国SLE患者中,GR基因rs10482672,rs12656106,rs4912905,rs4912911,rs4986593,rs7719514和rs9324924多态性可能与HRQOL的改善有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号